ArticleFrontiers in cardiovascular medicine2025
Machine learning algorithms to predict heart failure with preserved ejection fraction among patients with premature myocardial infarction.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Systematic review and meta - analysis of risk prediction models for heart failure after PCI in patients with acute myocardial infarction.BMC cardiovascular disorders · 2026Pooled it
- Machine Learning Applications for Risk Stratification in Heart Failure with Preserved Ejection Fraction: A New Era in Cardiology.Diagnostics (Basel, Switzerland) · 2026Review
- Prognostic Modeling of Tricuspid Valve Regurgitation Outcomes Using Machine Learning-Based Survival Analysis.Journal of clinical medicine · 2026Article
- Machine learning to identify heart failure with preserved ejection fraction in type 2 diabetes mellitus patients.Frontiers in cardiovascular medicine · 2026Article
- Facilitators, barriers, and insights using an HFA-PEFF-based clinical decision support system: A proof-of-concept study.ESC heart failure · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Heart Failure with Preserved Ejection Fraction (HFpEF) in patients with Premature Myocardial Infarction (PMI) is a crucial factor affecting long-term prognosis. This study aims to develop a model based on a machine learning algorithm that can predict the risk of in-hospital HFpEF in patients with PMI early and quickly. Methods: This prospective study consecutively included PMI patients from January 2017 to December 2022. Lasso-Logistic, XGBoost, Random Forest, K-Nearest Neighbor, and Support Vector Machine models were constructed. The prediction performance of the models was compared through AUC, Accuracy, Precision, F1 score, and Brier score. Shapley Additive exPlanations is used to explain the model. A prediction system was developed to identify high-risk patients. Results: The study finally included 840 PMI patients. 268 (31.90%) developed in-hospital HFpEF. The XGBoost model has the best prediction performance (AUC 0.854; Accuracy 0.798; Precision 0.686; F1 score 0.586; Brier score 0.143). The final model included ten variables, which were Brain natriuretic peptide (BNP) > 100pg/ml, SYNTAX Score > 14.5, Age, Monocyte to Lymphocyte Ratio (MLR) > 0.3, Hematocrit (HCT) < 45%, Heart rate (HR) > 75 bpm, Body Mass Index (BMI) ≥ 24 kg/m Conclusions: The explainable prediction model established based on the XGBoost algorithm can accurately predict the risk of in-hospital HFpEF in PMI patients and is available at https://hfpefpmi.shinyapps.io/apppredict/. This system is expected to assist clinicians in decision-making by providing timely, prioritized, and precise interventions for PMI patients, ultimately reducing the incidence of HFpEF and improving long-term prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.